A Single-Centre, Double-Blind, Randomized, Placebo-Controlled, 2-Arm Study to Evaluate the Safety and Efficacy of Once-Weekly Sirolimus (rapamycin) on Muscle Strength and Endurance in Older Adults Following a 13-Week Exercise Program.